Skip to main content

Centivax

Centivax develops broad-spectrum vaccines aimed at preventing infectious diseases across different species. Their current focus is on a universal influenza vaccine currently in pre-clinical development for ferrets and pigs. The company seeks to advance global health by creating preventative measures against widespread pathogens.

Traction –/10
South San Francisco, United States · HQ
253K+ followers
  • Biotechnology
Updated 5 months ago

Funding

Raised to date

$10MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

1 founder

Jacob Glanville

CEO

Product

Features

  • Centivax develops broad-spectrum vaccines aimed at preventing infectious diseases across different species. Their current focus is on a universal influenza vaccine currently in pre-clinical development for ferrets and pigs. The company seeks to advance global health by creating preventative measures against widespread pathogens.
This profile is AI-generated and may contain inaccuracies.